Skip to content

Withholding of Life-sustaining Treatment and Quality of Life After Severe Acute Brain Injury: Qualitative Analysis and Ethical Issues

Withholding of Life-sustaining Treatment and Quality of Life After Severe Acute Brain Injury: Qualitative Analysis and Ethical Issues.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06523127
Enrollment
14
Registered
2024-07-26
Start date
2024-06-03
Completion date
2024-09-30
Last updated
2024-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Post ICU, Quality of Life

Keywords

Quality of life, Withholding of life-sustaining treatments, Withdrawal of life-sustaining treatment, Severe acute brain injury

Brief summary

Withdrawal of life-sustaining treatment affects 10-15% of ICU patients, including those with severe acute brain injury, whose care appears futile in terms of prognosis based on clinical and paraclinical data, expected quality of life, patient preferences, age, or reduced quality of life. There are few studies on withholding treatment compared with withdrawing treatment, and even fewer on survivors after a decision to withhold treatment. Quality of life is defined by WHO as an individual's perception of his or her position in life in the context of the culture and value systems in which he or she lives and in relation to his or her goals, expectations, standards and concerns. The relationship between quality of life and neurological outcome after severe acute brain injury is controversial and therefore difficult to predict. That's why the investigators question the legitimacy of making decisions to withhold treatment from patients with severe acute brain injury based on their expected quality of life, when this prediction is uncertain.

Interventions

OTHERRecording data from the ICU stay and the post-ICU follow-up.

Record analysis of the post-ICU follow-up with the Interpretative Phenomenological Analysis

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients: * with severe acute brain injury (TBI, stroke, central nervous system infection). * admitted in the neurocritical care unit in 2022. * followed up 24 months after ICU between 15th April 2024 and 31st August 2024.

Exclusion criteria

Patients: * death in 2024, * refusal by patient or relative.

Design outcomes

Primary

MeasureTime frameDescription
Interpretative Phenomenological Analysis24 months after ICU dischargeQualitative analysis of the quality of life in patients with severe acute brain injury and with withholding of life-sustaining treatment

Secondary

MeasureTime frameDescription
International survey among neurointensivists from ANARLF network - questionnairesMonth : 3Comparison of the number of decisions of withholding treatment in the clinical cases versus real life
International survey among neurointensivists from ANARLF network - follow-upMonth : 3Comparison of the predicted neurological outcome and quality of life by neurointensivists versus the real neurological outcome and quality of life assessed at the post-ICU follow-up.

Countries

France

Contacts

Primary ContactMarie DAKENG, resident
mcgperret@gmail.com(0)4 77 82 83 29
Backup ContactNory ELHADJENE, MD
Nory.ELHADJENE@chu-st-etienne.fr(0)4 77 82 83 29

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026